Abstract | OBJECTIVE: METHODS: CIA was induced by intradermal injection of 100 μl of emulsion containing 100 μg of bovine type II collagen (CII) and complete Freund's adjuvant (CFA) at the base of the tail. On Day 21, a second injection of CII in CFA was administered. Immunized mice developed erosive hind paw arthritis. Macroscopic clinical evidence of CIA first appeared as periarticular erythema and edema in the hind paws. The incidence of CIA was 100% by Day 27 in the CII challenged mice and the severity of CIA progressed over a 35-day period, with radiographic evaluation revealing focal resorption of bone. The histopathology of CIA included erosion of cartilage at the joint margins. RESULTS: CONCLUSION: We demonstrate that CGS 21680 exerts an antiinflammatory effect during chronic inflammation and ameliorates the tissue damage associated with CIA.
|
Authors | Emanuela Mazzon, Emanuela Esposito, Daniela Impellizzeri, Rosanna DI Paola, Alessia Melani, Placido Bramanti, Felicita Pedata, Salvatore Cuzzocrea |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 38
Issue 10
Pg. 2119-29
(Oct 2011)
ISSN: 0315-162X [Print] Canada |
PMID | 21765105
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adenosine A2 Receptor Agonists
- Collagen Type II
- Interleukin-6
- Phenethylamines
- Tumor Necrosis Factor-alpha
- 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
- Nitric Oxide Synthase Type II
- Cyclooxygenase 2
- Adenosine
|
Topics |
- Adenosine
(analogs & derivatives, pharmacology, therapeutic use)
- Adenosine A2 Receptor Agonists
(pharmacology, therapeutic use)
- Animals
- Arthritis, Experimental
(drug therapy, metabolism, pathology)
- Cartilage, Articular
(drug effects, metabolism, pathology)
- Collagen Type II
(pharmacology)
- Cyclooxygenase 2
(metabolism)
- Disease Progression
- Interleukin-6
(metabolism)
- Joints
(drug effects, metabolism, pathology)
- Mice
- Nitric Oxide Synthase Type II
(metabolism)
- Phenethylamines
(pharmacology, therapeutic use)
- Tumor Necrosis Factor-alpha
(metabolism)
|